Vantage Funding Companions LLC minimize its place in stocks of Johnson & Johnson (NYSE:JNJ – Loose File) via 24.8% all the way through the second one quarter, in keeping with its most up-to-date Shape 13F submitting with the Securities and Trade Fee (SEC). The company owned 49,492 stocks of the corporate’s inventory after promoting 16,360 stocks all the way through the duration. Vantage Funding Companions LLC’s holdings in Johnson & Johnson have been value $8,192,000 on the finish of the latest quarter.

A variety of different institutional buyers additionally lately purchased and offered stocks of the corporate. Atlantic Personal Wealth LLC bought a brand new stake in stocks of Johnson & Johnson within the 1st quarter valued at roughly $32,000. Ruedi Wealth Control Inc. bought a brand new stake in stocks of Johnson & Johnson within the 4th quarter valued at roughly $42,000. 25 LLC bought a brand new stake in stocks of Johnson & Johnson within the 1st quarter valued at roughly $55,000. Horizons Wealth Control raised its stake in stocks of Johnson & Johnson via 1,730.0% within the 2d quarter. Horizons Wealth Control now owns 366 stocks of the corporate’s inventory valued at $61,000 after obtaining an extra 346 stocks all the way through the duration. In any case, Bay Harbor Wealth Control LLC bought a brand new stake in stocks of Johnson & Johnson within the 2d quarter valued at roughly $66,000. 68.40% of the inventory is owned via hedge price range and different institutional buyers.

Analyst Upgrades and Downgrades

A number of equities analysis analysts lately weighed in on JNJ stocks. Raymond James minimize their goal fee on stocks of Johnson & Johnson from $184.00 to $179.00 and set an “outperform” ranking at the inventory in a analysis observe on Tuesday, September fifth. Barclays upped their goal fee on stocks of Johnson & Johnson from $158.00 to $162.00 and gave the inventory an “equivalent weight” ranking in a analysis observe on Thursday. Cantor Fitzgerald reaffirmed an “obese” ranking and set a $215.00 goal fee on stocks of Johnson & Johnson in a analysis observe on Monday. Morgan Stanley upped their goal fee on stocks of Johnson & Johnson from $172.00 to $174.00 and gave the inventory an “equivalent weight” ranking in a analysis observe on Wednesday. In any case, StockNews.com raised stocks of Johnson & Johnson from a “purchase” ranking to a “strong-buy” ranking in a analysis observe on Tuesday. 9 equities analysis analysts have rated the inventory with a dangle ranking, six have given a purchase ranking and one has given a robust purchase ranking to the inventory. Consistent with MarketBeat, the inventory right now has a median ranking of “Reasonable Purchase” and a median fee goal of $171.39.

Get Our Newest Research on JNJ

Johnson & Johnson Buying and selling Up 0.1 %

Stocks of Johnson & Johnson inventory opened at $156.32 on Friday. The corporate has a fifty day easy transferring moderate of $163.35 and a 200-day easy transferring moderate of $162.41. Johnson & Johnson has a 12-month low of $150.11 and a 12-month prime of $181.04. The corporate has a present ratio of one.12, a handy guide a rough ratio of 0.88 and a debt-to-equity ratio of 0.44. The inventory has a marketplace cap of $406.27 billion, a price-to-earnings ratio of 31.64, a PEG ratio of three.21 and a beta of 0.55.

Johnson & Johnson (NYSE:JNJ – Get Loose File) remaining issued its revenue effects on Thursday, July twentieth. The corporate reported $2.80 revenue in line with percentage (EPS) for the quarter, beating the consensus estimate of $2.62 via $0.18. Johnson & Johnson had a web margin of 13.35% and a go back on fairness of 36.72%. The trade had income of $25.53 billion all the way through the quarter, in comparison to analysts’ expectancies of $24.63 billion. All over the similar quarter within the prior 12 months, the trade posted $2.59 EPS. The corporate’s income for the quarter used to be up 6.3% on a year-over-year foundation. On moderate, equities analysts forecast that Johnson & Johnson will put up 10.02 EPS for the present fiscal 12 months.

Johnson & Johnson Pronounces Dividend

The company additionally lately declared a quarterly dividend, which used to be paid on Thursday, September seventh. Buyers of report on Monday, August twenty eighth have been paid a dividend of $1.19 in line with percentage. This represents a $4.76 dividend on an annualized foundation and a yield of three.05%. The ex-dividend date of this dividend used to be Friday, August twenty fifth. Johnson & Johnson’s dividend payout ratio is lately 96.36%.

Insider Purchasing and Promoting

In similar information, VP Peter Fasolo offered 20,000 stocks of the inventory in a transaction on Tuesday, July twenty fifth. The stocks have been offered at a median fee of $170.32, for a complete transaction of $3,406,400.00. Following the of entirety of the sale, the vp now owns 102,696 stocks within the corporate, valued at roughly $17,491,182.72. The sale used to be disclosed in a file filed with the SEC, which will also be accessed via the SEC site. In different Johnson & Johnson information, insider William Hait offered 14,698 stocks of the corporate’s inventory in a transaction on Wednesday, July twenty sixth. The stocks have been offered at a median fee of $172.00, for a complete transaction of $2,528,056.00. Following the of entirety of the transaction, the insider now owns 87,747 stocks within the corporate, valued at roughly $15,092,484. The sale used to be disclosed in a prison submitting with the SEC, which will also be accessed via this hyperlink. Additionally, VP Peter Fasolo offered 20,000 stocks of the corporate’s inventory in a transaction on Tuesday, July twenty fifth. The inventory used to be offered at a median fee of $170.32, for a complete transaction of $3,406,400.00. Following the transaction, the vp now owns 102,696 stocks of the corporate’s inventory, valued at roughly $17,491,182.72. The disclosure for this sale will also be discovered right here. 0.20% of the inventory is owned via corporate insiders.

Johnson & Johnson Profile

(Loose File)

Johnson & Johnson, along side its subsidiaries, researches, develops, manufactures, and sells quite a lot of merchandise within the healthcare box international. The corporate’s Client Well being phase supplies pores and skin well being/attractiveness merchandise below the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX manufacturers; child care merchandise below the JOHNSON’S and AVEENO Child manufacturers; oral care merchandise below the LISTERINE emblem; TYLENOL acetaminophen merchandise; SUDAFED chilly, flu, and hypersensitive reaction merchandise; BENADRYL and ZYRTEC hypersensitive reaction merchandise; MOTRIN IB ibuprofen merchandise; NICORETTE smoking cessation merchandise; and PEPCID acid reflux disease merchandise.

See Additionally

Obtain Information & Scores for Johnson & Johnson Day by day – Input your e-mail cope with underneath to obtain a concise day by day abstract of the most recent information and analysts’ scores for Johnson & Johnson and similar firms with MarketBeat.com’s FREE day by day e-mail e-newsletter.